Manufacturing method patent for the sustained-release pellets containing tamsulosin hydrochloride

Acquired the patent for pellets and the manufacturing method, pellets expected to be available next year

Daewoong Pharmaceutical obtained the patent for the sustained-release pellets containing tamsulosin hydrochloride and manufacturing method in July 27.

It is possible to develop the sustained-release medicine containing tamsulosin hydrochloride featuring excellent stability. The method is the early bumping phenomenon is ameliorated by laying the semi-permeable membrane between the coating layer and the drug layer and which leads to the release of the medicine regularly regardless of the Ph of the body. The tamsulosin hydrochloride improves the prostate hyperplasia by blocking the sympathetic nerve selectively and affecting the prostate.

The pharmaceutical company has already achieved a conditional product license from the Korean Food and Drug Administration after completing the pilot production test with the method. The product will be available in 2008.